Moderna Inc. announces successful study for COVID-19 vaccine
Moderna Inc. released the latest data from its late-stage trial for its experimental coronavirus (COVID-19) vaccine, mRNA-1273, proving to be 94.5% effective in preventing COVID-19 infection. This exciting news makes Moderna Inc. the second U.S. drugmaker to report exceeding successful test results.
The COVID-19 vaccine created by Pfizer Inc. displayed success with over 90% effective treatment rate. The U.S. could have two vaccines authorized for emergency use by December with an estimated 60 million doses to be available by this year pending a regulatory review and more safety data.
One of the most exciting things about the Moderna vaccine is that unlike the Pfizer one which has to be kept at -75°C – this one stays stable for a month when kept at 2-8°C. Makes a huge difference when getting the vaccine out to hard to reach communitieshttps://t.co/RgpRnTYv0D
— Charlie Haynes (@charliehtweets) November 16, 2020
Both vaccines utilizing newly developed technology, messenger RNA (mRNA), that transforms the body to attract the cells to create virus proteins that the immune system can deem as a threat and attack the virus. The Moderna vaccine is delivered to patients in shots and the medicine can be stored at a normal fridge temperature that will help make the medicine more widely available for more people.
The late-stage trial conducted by Moderna involved 95 infections among trial participants that randomly received the placebo or vaccine. Only five of the volunteers of the study who received the mRNA-1273 vaccine were infected.
Patients of the mRNA-1273 trial were given two shots 28 days and Moderna expects to have enough safety data required to file for authorized emergency use in the upcoming weeks. Moderna is also apart of Operation Warp Speed that was an executive order signed by President Donald Trump to expedite testing and manufacturing COVID-19 vaccines in the fastest manner possible.
The President of Moderna Stephen Hoge claimed in a recent interview following the release of the data results that the pharmaceutical company would be ready to distribute immediately following authorized approval for release. Moderna Inc. expects they should be able to produce 20 million doses for the United States for 2020 once they get FDA authorization.
-
Taking Precautions in Uganda and Kenya for Safe Travels The U.S. Embassy has recently issued important security alerts for...
-
White House Reveals Disturbing Executions and Threats in Conflict The White House has disclosed deeply concerning information regarding the...
-
Military Exercises Coincide with Treaty Developments Amid Global Concerns Russia recently executed a large-scale military exercise to rehearse its...
-
China’s Ambitious Plans to Double Its Nuclear Warhead Stockpile Highlighted in Pentagon’s Annual Report The annual report released by...
-
Strengthening Partnerships and Providing Support in Challenging Times In a collaborative effort between the U.S. Congress and the White...
-
U.S. Stresses Peace and Humanitarian Aid in Israeli-Palestinian Conflict In an exclusive interview aired on Sunday, President Joe Biden...
-
Meta’s Oversight Board to Review Handling of Manipulated Biden Video Facebook’s refusal to remove a leaked video of President...
-
Congressman accused of credit card misuse and identity theft, as legal challenges persist. U.S. prosecutors have brought a fresh...
-
First-ever Criminal Prosecution of a Sitting President’s Child Sparks National Interest and Legal Debate In a landmark legal case,...
-
President Biden’s Performance Under a Strict Spotlight In the current climate of intense media scrutiny and heightened political divisions,...
-
Meghan, Duchess of Sussex, Rumored as Possible Contender for U.S. Senate Seat Recent reports have sparked speculation about Meghan,...
-
Preparations Underway as Government Shutdown Looms: What to Expect With a government shutdown looming, federal agencies are bracing for...